Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Miller, Carol D. [R-WV-1]

Rep. Miller, Carol D. [R-WV-1]

United States · Official source

Records

1,080 records where Rep. Miller, Carol D. [R-WV-1] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 6785 (119th)referred

CLEAR Act of 2025

United States · United States Congress · 17 December 2025

Bill· HRH.R. 6766 (119th)referred

Essential Caregivers Act of 2025

United States · United States Congress · 16 December 2025

Essential Caregivers Act of 2025   This bill prohibits certain health care facilities from limiting the access of essential caregivers to residents of those facilities, including during designated emergency periods.   Specifically, the bill generally prohibits Medicare skilled nursing facilities, Medicaid nursing facilities, Medicaid intermediate care facilities, and associated inpatient rehabilitation facilities from restricting the access of essential caregivers to residents of the facilities, including during emergency periods in which visitation rights are otherwise restricted. During emergency periods, facilities may restrict access for an initial period of up to seven days and for one additional maximum seven-day period (if the additional period is approved by the state health department). Facilities may restrict access for a total of 7 days (or 14 days with the approval of the state health department) during an emergency period. Essential caregivers must agree to comply with any safety protocols set by the facility, which may be no more stringent for caregivers compared to those for staff. Caregivers who fail to comply with these requirements may be denied access, subject to an appeals process.

Bill· HRH.R. 6707 (119th)referred

CFIUSMCA Act

United States · United States Congress · 15 December 2025

Bill· HRH.R. 6509 (119th)referred

SAFE Drugs Act of 2025

United States · United States Congress · 9 December 2025

Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2025 or the SAFE Drugs Act of 2025 This bill provides for increased oversight of drug compounding and imposes statutory limits on compounded drugs that are essentially copies of commercially available drugs. Currently, subject to certain requirements, compounded drugs (i.e., drugs that are mixed or altered to meet patient needs) do not require Food and Drug Administration (FDA) approval. Additional limits apply to the compounding of drugs that are essentially copies of commercially available drug products. Under the bill, a compounded drug is essentially a copy of a commercially available drug product if (1) the compounded drug contains any active ingredient found in a commercially available drug product, and (2) there is no change made for an individual patient that results in a significant difference between the compounded drug and the commercially available drug. (The FDA’s current definition of the term also addresses dosage strength and route of administration.)  The bill increases the frequency at which a licensed pharmacist or physician may compound a drug that is essentially a copy of a commercially available drug to 20 times per month. Current FDA policy allows four such prescriptions per month. The bill also imposes annual reporting requirements on physicians, facilities, and pharmacies (except hospital-based pharmacies) that compound certain drug products for out-of-state patients more than 20 times per month. Further, the bill subjects certain large-scale outsourcing facilities (i.e., FDA-registered facilities that compound in bulk) to regular inspection and reporting requirements.

Resolution· HRESH.Res. 923 (119th)passed

A resolution honoring the service and sacrifice of United States Army Specialist Sarah Beckstrom and United States Air Force Staff Sergeant Andrew Wolfe, who were tragically shot in Washington, D.C., in a targeted assault against United States service members on November 26, 2025.

United States · United States Congress · 3 December 2025

This resolution honors the service and sacrifice of U.S. Army Specialist Sarah Beckstrom and U.S. Air Force Staff Sergeant Andrew Wolfe as members of the West Virginia National Guard and extends sympathy, gratitude, and support for their families in the wake of the attack on November 26, 2025, in Washington, DC. The resolution also honors the bravery of the other National Guard members on the scene, expresses gratitude for the action of first responders, and condemns the attack.

Bill· HRH.R. 6407 (119th)referred

RCORP Authorization Act

United States · United States Congress · 3 December 2025

Bill· HRH.R. 6199 (119th)referred

Medical Nutrition Therapy Act of 2025

United States · United States Congress · 20 November 2025

Medical Nutrition Therapy Act of 2025 This bill expands Medicare coverage of medical nutrition therapy services. Currently, Medicare covers such services for individuals with diabetes or kidney disease under certain circumstances; such services must also be provided by a registered dietitian or nutrition professional pursuant to a physician referral. The bill extends coverage to individuals with other diseases and conditions, including obesity, eating disorders, cancer, and HIV/AIDS; such services may also be referred by a physician assistant, nurse practitioner, clinical nurse specialist, or (for eating disorders) a clinical psychologist.

Bill· HRH.R. 6182 (119th)referred

Find It Early Act

United States · United States Congress · 20 November 2025

Bill· HRH.R. 6130 (119th)referred

ASAP Act

United States · United States Congress · 19 November 2025

Bill· HRH.R. 5917 (119th)referred

To authorize the extension of nondiscriminatory treatment (normal trade relations treatment) to products of certain countries.

United States · United States Congress · 4 November 2025

This bill addresses trade between the United States and covered countries. Under this bill, a covered country is any country excluding Belarus, Cuba, and North Korea. Specifically, the bill authorizes the President to determine that Section 402 of the Trade Act of 1974 (commonly known as the Jackson-Vanik amendment) does not apply to a covered country. The Jackson-Vanik amendment denies normal trade relations (NTR) status to some current and former nonmarket economy countries unless they comply with certain freedom-of-emigration requirements. Under a provision of this amendment, the President may extend NTR status to a country affected by the amendment by waiving the freedom-of-emigration requirements or determining that the country is not in violation of those requirements, subject to an annual review. Additionally, the bill authorizes the President to extend permanent NTR status to a covered country.

Resolution· HRESH.Res. 719 (119th)passed

Honoring the life and legacy of Charles Charlie James Kirk.

United States · United States Congress · 16 September 2025

This resolution (1) condemns the assassination of Charles "Charlie" James Kirk and all forms of political violence; and (2) honors the life, leadership, and legacy of Charlie Kirk.

Bill· HRH.R. 5343 (119th)reported

Ensuring Patient Access to Critical Breakthrough Products Act

United States · United States Congress · 15 September 2025

Ensuring Patient Access to Critical Breakthrough Products Act This bill provides for Medicare coverage of medical devices that are approved under the Food and Drug Administration (FDA) Breakthrough Devices Program. (Under the program, manufacturers work with the FDA to expedite the review and approval of certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions.) The bill allows designated medical breakthrough devices to be temporarily covered under Medicare during a four-year transitional period. Manufacturers must apply to the Centers for Medicare & Medicaid Services (CMS) to receive this designation. Qualifying devices must (1) have received priority review from the FDA, (2) received premarket approval (if applicable) based on clinical data that includes data from Medicare beneficiaries, (3) already generally qualify for Medicare coverage, and (4) not present an undue risk of harm that outweighs potential clinical benefits for Medicare beneficiaries. The CMS must approve or deny applications within six months of receipt and must provide an explanation in the case of a denial. In addition, the CMS must make permanent coverage decisions before the end of the transitional period upon a timely request to do so, as specified. The bill provides funds through FY2030 for the CMS to implement the bill.

Bill· HRH.R. 5267 (119th)reported

American Franchise Act

United States · United States Congress · 10 September 2025

Bill· HRH.R. 5269 (119th)referred

RESULTS Act

United States · United States Congress · 10 September 2025

Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 or the RESULTS Act This bill requires the use of particular data from the private sector to inform Medicare payment rates for certain widely available laboratory tests.  Specifically, the Centers for Medicare & Medicaid Services (CMS) must contract with an entity that maintains a database of claims data for clinical diagnostic laboratory tests that (1) are not advanced diagnostic tests, and (2) were furnished by more than 100 providers and suppliers of such services over a specified six-month period (i.e., widely available tests). The database must meet specified requirements, such as having data that is representative of the entire country and from more than 50 private payors and claims administrators. The contracted entity must be a nonprofit entity that is not affiliated with any government agency, any insurance issuer or provider, or any other organization in the health care sector.  Beginning January 1, 2028, the CMS must use the information obtained from the database to inform Medicare payment rates for these widely available laboratory tests.  The bill additionally specifies processes for determining payment rates for laboratory tests that are not advanced diagnostic tests, are not widely available, and lack adequate claims data. The CMS must use certain existing processes to set appropriate rates. The bill also delays scheduled payment reductions for laboratory tests until 2028 and allows for judicial and administrative review of payment rates. 

Bill· HRH.R. 5223 (119th)referred

RESTORE Act of 2025

United States · United States Congress · 9 September 2025

Bill· HRH.R. 4930 (119th)referred

To expand the sharing of information with respect to suspected violations of intellectual property rights in trade.

United States · United States Congress · 8 August 2025

This bill expands the authority of U.S. Customs and Border Protection (CBP) to provide information to certain persons (e.g., trademark or copyright owners) regarding suspected violations of intellectual property rights in trade.  Under current law, if CBP suspects that merchandise is being imported in violation of certain trademark and copyright laws, it may request assistance from specified persons when determining whether the merchandise is imported in violation of these laws. To permit the party to conduct examination and testing, CBP must provide them with specified information that appears on the merchandise and its packaging and labels.  This bill (1) expands the definition of person to allow CBP to request assistance from any other appropriate party with an interest in the imported merchandise, and (2) expands the scope of information that CBP is authorized to share with others to include information on and images of packing materials and containers. The bill allows CBP to request this assistance if it has a reasonable suspicion (currently, suspects) that the merchandise being imported is in violation of certain trademark and copyright laws. Additionally, CBP may provide a person with nonpublic information about the imported merchandise that was generated by an online marketplace or similar market platform, express consignment operator, freight forwarder, or any other entity that plays a role in the sale, importation, or facilitation of the merchandise into the United States and has been provided to, shared with, or obtained by CBP. CBP must provide the person with notification of the transmitted information.

Bill· HRH.R. 4792 (119th)referred

Protecting Air Ambulance Services for Americans Act of 2025

United States · United States Congress · 29 July 2025

Protecting Air Ambulance Services for Americans Act of 2025 This bill authorizes payment changes under Medicare for air ambulance services based on certain collected data and requires additional reporting from providers of these services. Current law requires providers of air ambulance services to report certain information regarding general costs and utilization to the Department of Health and Human Services; private health insurers are also required to report information relating to coverage of these services. The bill authorizes the Centers for Medicare & Medicaid Services to revise payment rates under Medicare for air ambulance services based on this data, and it requires providers of air ambulance services to specifically report information relating to costs and utilization under Medicare. The bill also requires the Government Accountability Office to report on the data that is collected under current law requirements and to recommend changes to Medicare payment rates accordingly.

Bill· HRH.R. 4780 (119th)referred

USTRx Act

United States · United States Congress · 29 July 2025

Bill· HRH.R. 4669 (119th)reported

FEMA Act of 2025

United States · United States Congress · 23 July 2025

Fixing Emergency Management for Americans Act of 2025 or the FEMA Act of 2025 This bill reestablishes the Federal Emergency Management Agency (FEMA) (currently within the Department of Homeland Security) as an independent, cabinet-level agency. It also makes broad changes to FEMA’s disaster and hazard mitigation assistance programs. The bill generally transfers FEMA’s current functions and authorities to the independent FEMA, except for certain security-related programs.  The bill makes various changes to the Public Assistance program, including by establishing new grants for expedited funding to repair or replace disaster-damaged facilities, establishing block grants that recipients may choose instead of Public Assistance for smaller disasters, expediting and expanding uses of funding for emergency response and debris removal, and allowing use of excess administrative funds for increasing recipients’ disaster management capacity.  The bill makes various changes to the Individual Assistance program, including by expanding eligibility for housing assistance, expanding mitigation and direct (non-financial) assistance for residences, reducing certain restrictions on funds duplicating program benefits, and  establishing a unified disaster application system. The bill makes various changes to FEMA’s mitigation programs, including by establishing mitigation plans with preapproved projects, authorizing an entire Hazard Mitigation Grant Program grant to be provided before costs are incurred, changing pre-disaster mitigation assistance to noncompetitive formula grants, and  allowing recipients to combine mitigation project funds from multiple federal programs. Additionally, federal entities must publish various information relating to disaster assistance and conduct various studies on related topics (e.g., preliminary damage assessments, fast-moving disasters, and government emergency alerting systems). 

Bill· HRH.R. 4607 (119th)referred

SEEK HELP Act

United States · United States Congress · 22 July 2025